R&D Recent breakthroughs in 3D bioprinting: A look at trends and... 3D bioprinting technology is bringing a new revolutionary wave to the healthcare industry.
Partner Content Partner Content SMi’s 3D Cell Culture Conference 2021 – Speakers Announced SMi’s 3D Cell Culture Conference 2021
Partner Content Partner Content Speaker interview MRC Harwell Institute ahead of SMi’s 3D Ce... Speaker interview MRC Harwell Institute
News Taiho's late-stage Duchenne candidate fails trial Taiho has suffered a blow to its near-term pipeline after a drug candidate for Duchenne muscular dystrophy (DMD) missed the mark in a phase 3 trial.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face